EDGE
Book a demo

All Updates

Filter
Last week:
Funding
Seamless Therapeutics raises EUR 11.8 million in seed funding
Human Gene Editing
Mar 16
Funding
Chroma Medicine raises USD 135 million in Series B funding
Human Gene Editing
Mar 1
Earnings/results
Editas Medicine reports 23% drop in revenue for FY2022
Human Gene Editing
Feb 22
Partnerships
Moderna and ElevateBio’s Life Edit Therapeutics sign gene-editing deal
Human Gene Editing
Feb 22
Earnings/results
CRISPR Therapeutics provides an FY2022 update and 2023 outlook
Human Gene Editing
Feb 21
Partnerships
Arbor Biotechnologies and Vertex Pharmaceuticals partner to develop genetic medicines
Human Gene Editing
Jan 17
Funding
CRISPR QC raises USD 1.6 million in seed funding
Human Gene Editing
Jan 10
Earnings/results
Precision Biosciences provides an FY2022 update and 2023 outlook
Human Gene Editing
Jan 9
Funding
Metagenomi raises USD 100 million in Series B extension
Human Gene Editing
Jan 5
Funding
M&A
Ensoma raises USD 85 million and acquires Twelve Bio
Human Gene Editing
Jan 5
Funding
Jalon Therapeutics raises a total funding of USD 2.1 million
Human Gene Editing
Dec 16, 2022
Industry news
First leukemia patient shows no sign of cancer after base editing treatment
Human Gene Editing
Dec 11, 2022
Funding
Intellia Therapeutics to raise USD 300 million in underwritten public offering
Human Gene Editing
Nov 30, 2022
Funding
iECURE raises USD 65.1 million in Series A-1
Human Gene Editing
Nov 30, 2022
M&A
AstraZeneca acquires LogicBio Therapeutics for gene editing technologies
Human Gene Editing
Nov 16, 2022
Funding
Excision BioTherapeutics secures USD 6.9 million grant to support clinical trials
Human Gene Editing
Sep 29, 2022
Funding
SparingVision raises EUR 75 million in Series B
Human Gene Editing
Sep 14, 2022
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.